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Background/aim: Acute aortic dissection (AAD) is a rare but fatal disease if left untreated. Symptoms are often similar to common
conditions; therefore, the diagnostic strategy is important. We aimed to identify the atypical symptoms in a timely manner without
putting patients at greater risk for undetected AAD.
Materials and methods: We conducted a retrospective observational study of 59 AAD patients with both atypical and typical symptoms
from January 2012 to December 2016. Patients with atypical symptoms continuing more than 30 min underwent a D-dimer test and
computed tomography (CT) or computed tomographic angiography (CTA).
Results: Of the 59 AAD patients, 22 were atypical. In the atypical group, the median delay time in our hospital was 3.1 h; average delay
time after July 2015 was shorter than average delay time before June 2015 (16.59 ± 24.70 vs. 1.90 ± 0.57 h, P = 0.076).
Conclusions: For patients in the emergency department who are suspected of having AAD, incorporating atypical symptoms with
high levels of D-dimer into a triage strategy could improve the efficiency of clinical decision making. Furthermore, essential education
directed towards the recognition of the atypical symptoms of AAD for front-line physicians may aid in a timely diagnosis, as compared
with the usual assessments in the emergency department.
Key words: Acute aortic dissection, atypical symptoms, assessment, diagnosis, D-dimer, computed tomography, computed tomographic
angiography

1. Introduction
Acute aortic dissection (AAD) is a rare but often
catastrophic disease. Prompt and accurate diagnosis is
crucial for survival. The incidence of aortic dissection
has been steadily increasing, from 29 to 150 cases per 1
million of the population per year during a more recent
period [1–3]. This increase may be attributed to the
improved diagnostic equipment and case ascertainment
[1–6]; however, a correct diagnosis of AAD is made in
only 15% to 43% of patients initially thought to have the
disease. Irrespective of the underlying mechanism, there
is an obvious increase in prevalence [1–3,7]. Previous
hospital-based studies from specialized centers or studies
from retrospective registry data [1–3,8,9] indicate that a
delay of 4.3 to more than 24 h occurs between presentation
and diagnosis of AAD [9]. According to the records of
untreated patients, the associated mortality is 1% per h
immediately after the onset of symptoms [1,2,7]; however,
previous studies have not detailed sufficient information

during this interval or indicated how to shorten the
delay between patient arrival and identification of AAD.
The present study provides an in-depth discussion on
how to identify atypical patients promptly and suggests
diagnostic strategies to decrease delays in the diagnosis
of AAD.
AAD is classified based on the anatomic distribution
of the dissection, time from symptom onset, and presence
of complications. However, the diagnosis of AAD is
particularly challenging due to a combination of highly
heterogeneous clinical presentation symptoms. Clinical
guidelines suggest that AAD should be considered in all
patients presenting with chest pain, back pain, abdominal
pain, and syncope, or symptoms consistent with perfusion
deficit, but these symptoms account for large proportions
of emergency medical visits worldwide [1,7]. Validated
diagnostic strategies are therefore needed to assist clinical
evaluation and pay more attention to atypical patients
without typical symptoms.
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2. Materials and methods
2.1. Selection of patients
This study was a retrospective observational study of
prospectively collected data to evaluate the efficacy and
safety of the diagnostic strategy for atypical AAD from
January 1, 2012, to December 31, 2016. Collected data
included records of dates and times of symptom onset,
clinical presentations, medical histories, physical findings,
laboratory examinations, imaging use and results,
emergency management, and outcomes. We incorporated
patients’ actual descriptions into the following definitions
of atypical symptoms—these include new or change in
intensity or frequency and intermittent—they are: (1) light
back or abdominal pain, (2) feeling of impending death,
(3) unusual fatigue, (4) dyspnea, etc. Atypical symptoms
are noncontinuous severe chest, back, and abdominal
pain, palpitations, etc.; in other words, persistent acute
symptoms are not the atypical ones. The geographic sector
of this study includes the metropolitan area of Maanshan
and its affiliated county, Dangtu, Anhui, China, which
is comprised of a stable population of approximately
1,200,000 people in the time frame of our study period.
All cases of AAD confirmed by computed tomography
(CT) or computed tomographic angiography (CTA) were
either operated on or treated with endovascular stentgraft placement or drugs in our hospital and at Nanjing
Drum Tower Hospital, the Affiliated Hospital of the
Medical School of Nanjing University, Nanjing, Jiangsu,
China. Patients older than 18 years were selected, resulting
in inclusion of 71 patients during the study period; 59
patients were diagnosed in the emergency department and
were enrolled in the study. The remaining 12 patients were
diagnosed during the duration of their hospital stay and
were not included in the study because they did not visit
our emergency department.
All 59 individuals diagnosed with AAD in our
emergency department underwent cross-sectional
imaging of the chest and/or abdomen using spiral CT/CTA
to confirm an AAD diagnosis. If a differential diagnosis
was needed, further examinations included a D-dimer
test, electrocardiography (ECG), and cardiac enzyme
tests. AAD was defined as the separation of the aortic wall
layers with resulting true and false lumens or intramural
hematoma.
This study was conducted in accordance with the
declaration of Helsinki. This study was conducted with
approval from the Ethics Committee of Maanshan People’s
Hospital. Written informed consent was obtained from all
participants (2017–009).
2.2. Laboratory examinations and triage course
When patients with atypical symptoms arrived in our
emergency department, they underwent three to five
routine emergency laboratory examinations as follows:

routine blood checkup, C-reactive protein (CRP), ECG,
liver and kidney function, serum electrolyte analysis, serum
and urine diastase, blood clotting tetrachoric, cardiac
enzymes, and troponin I. When we found high levels
of lactate dehydrogenase (LDH) and/or creatine kinase
(CK) (before July, 2015) and the patient had difficulty in
explaining their atypical symptoms, we administered the
D-dimer test; a CT or CTA was indicated according to the
result of the D-dimer test [10–16] because rapid diagnosis
of AAD is possible when CT or echocardiography are part
of the diagnostic testing [4,6,17–19]. Thus, we performed
imaging for patients with suspected AAD using a helical
CT scanner of 64 or 16 to identify their diagnosis as soon
as possible. A diagram on how we identified AAD patients
with atypical symptoms is shown in Figure 1.
We found that CK and LDH had the same significant
value in AAD diagnostic course between atypical and
typical group (CK, P = 0.877; LDH, P = 0.615), but the
delay time was shorter after July 2015 (before July 2015,
16.59 ± 24.70 h, after July 2015, 1.90 ± 0.57 h, P = 0.076)
because we provided our front-line physician education
regularly and discussed every atypical AAD in our
department before July 2015.
2.3. Assessment in the emergency department
According to the first evaluation by triage nurses, patients
arrive at our emergency department and are assigned
to different departments, such as internal medicine,
emergency surgery, or the intensive-care room of the
emergency department (IRED). Based on the physician’s
judgment, patients in our IRED can be immediately
hospitalized, referred, and consulted by related specialists
and even several directors; repeated evaluations and new
diagnostic strategy are carried out if a patient’s illness is
complicated and a diagnosis could not be identified in
time.
Within our department, patients who are considered
to have a high or moderate risk must have a definitive
diagnosis. Patients in whom it is difficult to identify a
diagnosis during the night shift must stay in the emergency
department and await a decision the next morning. All
admissions are referred or approved by a related specialist,
which differs from the emergency department principles of
the United States of America and other western countries
[17]. We study every atypical AAD patient and discuss
their diagnostic course with our front-line physicians.
2.4. Clinical management
Intravenous antihypertensive treatment should be started
urgently in all patients with hypertension, except in those
with hypotension, as soon as AAD is suspected. The
aims of medical therapy are to ease the systemic arterial
pressure to as low a level as possible (around 100 mmHg)
[20]. A combination of ß-blocker and vasodilator (i.e.,
sodium nitroprusside) is the standard medical therapy
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Figure 1. Diagram of AAD patients with atypical symptoms.

used in patients with suspected AAD [7,20]. Due to limited
conditions, we prescribe 50–100 mg metoprolol orally,
if without contraindications, to achieve a target heart
rate of 60 beats per min, alongside intravenous sodium
nitroprusside. Intravenous opiate analgesia is one of the
most significant agents for AAD patients; intravenous
morphine at 3 to 5 mg every 30 min will not only relieve
severe chest pain, but also augment the effects of heart rate
control and vasodilator agents.
2.5. Statistical analysis
We report data for the normal and skewed distributions
as mean ± standard deviation (SD) or as median (IQR)
and others as frequency (percentages). Normally
distributed variables compared between two groups use
Student’s t-test and others use the Mann–Whitney U-test.
Categorical variables were compared by the Pearson chisquare test or Fisher’s exact test. P-values of less than 0.05
were considered to indicate statistical significance. All
analyses were carried out using SPSS (version 18.0; IBM
SPSS Statistical, NY, USA).
3. Results
3.1. Groups of patients
We found 59 AAD patients during our study period
according to their diagnostic course; 22 atypical and
37 typical AAD patients were enrolled in the study. Ten
atypical patients from July 2015 were diagnosed according
to the presence of atypical symptoms and an increased
D-dimer, without examination of LDH and CK levels. The
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average age was 56.73 ± 13.85 years in the atypical group
and 64.19 ± 11.69 years in the typical group (t = 2.212, P
= 0.03). The sex distribution was 16 males and 6 females
in the atypical group, and 24 males and 13 females in the
typical group (χ2 = 0.391, P = 0.53). There were 15 (68.18%)
type B and 7 (31.82%) type A patients in the atypical group
and 24 (64.86%) type B and 13 (35.14%) type A patients in
the typical group (χ2 = 0.068, P = 0.79).
3.2. Clinical manifestations
Twenty-two (37.29%) of the atypical AAD patients did
not experience severe chest pain during the study period.
Sudden prolonged chest pain was the initial symptom in
25 (42.37%) of the 59 patients, often with a sharp, searing
pain lasting no more than 30 min, followed by a painless
or tolerable pain period. Abdominal pain was the first
symptom in 9 (15.25%) of the 59 patients, which was
often associated with severe cramps and shared the same
time interval as the chest pain; however, these patients
were younger and had few physical finds. Back pain was
the first symptom in 3 (5.09%) of the 59 patients. AAD
without pain occurred in 15 (25.42%) of the 59 patients
with normal vital signs; however, they had the following
atypical symptoms of AAD: palpitations, feeling of
impending death, tachypnea, dyspnea, unusual fatigue,
obscure dread, and light back and abdominal pain. The
atypical symptoms and other relative characteristics in
the atypical AAD patients are shown in Table 1. Even with
sufficient symptomatic treatment, their symptoms did not
improve or become worse.
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Table 1. Baseline characteristics and presenting symptoms of patients with acute aortic dissection.
Atypical group (%)
n = 22

Typical group (%)
n = 37

P-value

Age (years)

56.73 ± 13.85

64.19 ± 11.69

0.031

Male

16 (72.73)

24 (64.86)

0.532

Hypertension

7 (31.82)

31 (83.78)

<0.001

Severe chest pain

0

25 (67.57)

<0.001

Severe back pain

0

9 (24.32)

0.012

Severe abdominal pain

0

3 (8.11)

0.170

Palpitations

17 (77.27)

21 (56.76)

0.111

Tachypnea

15 (68.18)

29 (78.38)

0.384

Obscure dread

13 (59.09)

3 (8.11)

<0.001

Unusual fatigue

12 (54.55)

0

<0.001

Feeling of impending death

10 (45.45)

0

<0.001

Dyspnea

9 (40.91)

3 (8.11)

0.002

Light back or abdominal pain

7 (31.82)

0

<0.001

AAD, Stanford type B

15 (68.18)

22 (59.46)

0.774

Time from admission to a definite
diagnosis delay time (median [min])

186

31

0.006

≤1 h

1 (4.55)

35 (94.60)

0.001

1–2 h

7 (31.82)

1 (2.7)

0.002

2–4 h

8 (36.36)

1 (2.7)

<0.001

>4 h

6 (27.27)

0

<0.001

Presenting symptoms

Time from admission to a definite diagnosis in atypical group (h)
From January 2012 to June 2015 From July 2015 to December 2016
16.59 ± 24.70

1.90 ± 0.57

0.076

Note: Statistical difference between the two groups exists for some symptoms including severe chest and back pain,
obscure dread, unusual fatigue, feeling of impending death, dyspnea, light back or abdominal pain and delay time,
while others are not statistically significant.

3.3. Laboratory examinations
Of the 12 atypical AAD patients from January 2012 to
June 2015, all had undergone urgent examination of
LDH (range 313–618 IU/L) and CK (range 55–170 IU/L)
levels. Three abnormal LDH and 3 abnormal CK results
were found in 5 patients; the range of LDH was 202–850
IU/L and of CK 40–448 IU/L. Nine of the 12 atypical AAD
patients underwent the D-dimer test (range 0–550 µg/L),
8 of which had abnormal results with a range of 390–4380
µg/L. Of the 31 typical AAD patients from January 2012 to
June 2015, 14 underwent an examination of LDH and CK.
Abnormal LDH and CK results were found in 7 and 4 of 7
patients, respectively; LDH ranged from 462–870 IU/L and
CK from 42–283 IU/L. Seventeen typical AAD patients
underwent a D-dimer test; 13 patients had abnormal
results, ranging from 160–71,200 µg/L. The Pearson chi-

square test was used to compare the atypical and typical
groups (LDH, P = 0.615; CK, P = 0.877; D-dimer, P = 0.63).
3.4. Delay time in the emergency department
The median delay time of 22 atypical patients in our
emergency department was 3.1 h (minimum: 1.0 h;
maximum: 88.3 h; IQR: 5.4 h). The mean delay time of the
atypical AAD patients diagnosed in the emergency setting
was 88.3 h in 2012, 25.80 ± 40.02 h in 2013, 15.68 ± 26.50
h in 2014, 7.26 ± 9.12 h in 2015, and 2.41 ± 1.02 h in 2016.
The statistical results are presented in Figure 2 and Table 2.
3.5. Imaging and testing
Patients with atypical symptoms in whom it was difficult
to choose a diagnostic strategy underwent a CT or CTA
for a rapid diagnosis. Rapid diagnosis of AAD is possible
when CT or echocardiography are part of the diagnostic
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Figure 2. Delay time in atypical AAD patients according to quantity, with median
(box), and IQR (bold line).
Table 2. The findings of age and sex of 59 AAD patients by year.
2012 (%)

2013 (%)

2014 (%)

2015 (%)

2016 (%)

No.

7

9

13

18

12

Male

6 (85.71)

7 (77.78)

9 (69.23)

11 (61.11)

8 (66.67)

63.67 ± 6.35

65.25 ± 13.70

55.29 ± 14.82

52.14 ± 14.78

3 (33.33)

4 (30.77)

7 (38.89)

7 (58.33)

25.80 ± 40.02

15.68 ± 26.50

7.26 ± 9.12

2.41 ± 1.02

2 (50)

2 (28.57)

3 (42.86)

Age in atypical group※
No. of atypical AAD
Delay time in atypical group§

1 (14.29)

CT in atypical group

Note: ※P = 0.532, §P = 0.583. Delay time in atypical group is not statistically significant during five years but shows an obvious
decline tendency.

testing [4,6,17–19,21]. Thus, we performed imaging for
patients with suspected AAD using a helical CT scanner
of 64 or 16 to identify their diagnosis as soon as possible.
In this study, CT was conducted in 32 patients (84.38%
positive, all AAD patients diagnosed by CT in our hospital
were confirmed by CTA in Nanjing Drum Tower Hospital)
and CTA in 34 patients (94.12% positive). An example CT
image is shown in Figure 3.
3.6. Outcome of AAD patients
Fifty-three patients with a diagnosis of AAD were
transferred to Nanjing Drum Tower Hospital as soon
as possible. Fifty-two of these patients survived, and
there was 1 recorded death before arrival at Nanjing. Six
patients were hospitalized in our hospital; 1 was treated
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with endovascular stent-graft placement, and 5 were
administered drugs to control the disease.
4. Discussion
Failure to recognize the atypical symptoms of AAD may
be one reason why patients without the manifestation
of hypertension and severe chest pain experience longer
delays in diagnosis than those with hypertension and
typical chest pain. This could explain why AAD is
reported to be the primary cause of death in these patients
[1,2,7,9]. Timely diagnosis is essential for successful
management; determination of the most important factors
contributing to diagnostic and treatment delays is likely
to improve the diagnostic and decision-making process.

JIANG et al. / Turk J Med Sci

Figure 3. AAD found by chest CT; the arrow points to the inner
wall of aortic blood vessel.

Around 15%–43% of patients later found to have AAD
are initially suspected of having other conditions, such
as acute coronary syndromes, nondissecting aneurysms,
pericarditis, pulmonary embolism, or even cholecystitis
[7,22]; thus, the differential diagnosis of AAD should be
considered in patients presenting with atypical symptoms.
We report that 37.29% of AAD patients are atypical, which
is higher than in previous reports [23,24]. Furthermore,
we found 25.42% of atypical patients to be without any
pain, which is also higher than in some recent reports
(6.4%–17%) [23,24]. A possible explanation is that atypical
patients without pain in this study were at an earlier disease
stage than those in other studies [23–25], which perhaps is
attributed to our repeated education in the recognition of
atypical AAD for our front-line physicians. The mean age
of atypical patients in this study was 56.73 years, which
was somewhat younger than in previous reports [23,24]
and the Stanford classification of aortic dissection was not
different between the two groups (P = 0.774); the reason
for these is not clear.
So, how do we determine suspected AAD? When
patients present with atypical symptoms increasingly
frequently, or symptoms become aggravated despite
symptomatic treatment, new atypical symptoms emerge
during their stay in the emergency department. It becomes
difficult to exclude the possibility of severe diseases;
therefore, we pay more attention to certain high-risk
illnesses such as AAD, pulmonary embolism, and acute
coronary syndromes.
A combination of high D-dimer level [10–16] and
atypical symptoms would be an effective method of
diagnosing suspected AAD. A high level of LDH suggests
hemolysis within a false lumen [1]; therefore, measurements
of high levels of D-dimer, LDH, and CK were recommended

in the initial management of patients with suspected AAD
by the European Society of Cardiology [26]. CT or CTA
was then used alongside a high measurement of D-dimer,
LDH, and CK to confirm diagnosis of AAD. Before July
2015, we diagnosed 12 atypical AAD patients and found
no statistical significance between atypical and typical
groups, irrespective of the underlying mechanism of AAD,
which is consistent with previous reports [1,26]. D-dimer
levels below 500 µg/L may rule out suspected AAD if
determined within the first 24 h after symptom onset
[11,13]. A D-dimer level of <100 µg/L will exclude AAD
in all cases (the lowest measurement in the present study
was 160 µg/L, which is consistent with previous reports)
[27]. The use of the D-dimer test to discriminate between
AAD and acute myocardial infarction was effective in the
emergency setting [28]; thus, we performed a D-dimer test
for patients with suspected AAD without examination of
LDH and CK from July 2015, which achieved satisfying
results.
The atypical AAD symptoms found in this study were
palpitations, tachypnea, obscure dread, light back and
abdominal pain, unusual fatigue, feeling of impending
death, and dyspnea. Palpitations, tachypnea, obscure
dread, and light back and abdominal pain were usually
the first atypical symptoms, followed by unusual fatigue,
feeling of impending death, and dyspnea as secondary
symptoms. Acute chest pain was absent in atypical AAD.
Unusual fatigue and light back and abdominal pain were
the most negligible and mild symptoms in these patients
and were hardly associated with AAD. Tachypnea, obscure
dread, feeling of impending death, and dyspnea were
the severest of the symptoms; however, other diseases
were often considered in patients with these symptoms
before we studied their relation to AAD in-depth and
provided enough education to our front-line physicians.
The symptoms were often present for more than 1–2 days,
sometimes lasting up to a week, resulting in the patient
visiting the emergency department or clinic on repeated
occasions. Laboratory and physical examinations often
did not appear normal and symptomatic treatment
was ineffective [24,29,30]. In this study, we describe the
primary atypical symptoms of AAD as dyspnea, obscure
dread, unusual fatigue, feeling of impending death,
and light back and abdominal pain; palpitations and
tachypnea are present in both the atypical and typical
AAD groups. Previous studies have reported that dyspnea
was a possible “clinical confounder” in making a diagnosis
of painless AAD [24,29,30]. Palpitations as a symptom
were previously described in a case report [29]; the
other frequent symptoms and signs, including syncope,
hemiplegia, pleural effusion, and pulse deficits, have also
been previously described [24,29–31]. We did not observe
these symptoms in our study, which may be because we
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identified these patients at an earlier stage [24,29,30].
The median delay duration for atypical AAD patients
in our emergency department was 3.1 h (minimum: 1.0
h; maximum: 88.3 h; IQR: 5.4 h). The delay time in this
study is shorter than in previous reports [9,23]. A definite
diagnosis of AAD was made within 1 h of admission in
only 4.55% of patients in the atypical group (Table 1);
however, this trend has gradually changed as front-line
physicians are increasingly aware to suspect AAD based
on symptoms, physical findings, and results of initial
diagnostic tests such as the D-dimer, LDH, and CK tests.
The indications for clinical suspicion of AAD had been
concluded by July 2015. After July 2015, the delay time
(1.9 h) has improved greatly and was shorter than in some
previous reports (9,23,24,30). This provides evidence that
our method is effective in the diagnosis of atypical AAD,
without putting patients at risk for misdiagnosis; however,
the improved delay time (Table 1) did not reach statistical
significance (P = 0.08). Furthermore, the essential
education of front-line physicians in the recognition of the
atypical symptoms of AAD may be helpful in the clinical
decision of diagnosis.
Why do we choose CT or CTA as the first choice for
AAD diagnosis [4,6,21]? Not only is it one of the most
convenient examinations in our hospital and is accepted
by common people in China, but it is also supported by
the literature to help in the diagnosis of patients highly
suspected of having AAD [7,9,32]. The improvement in
diagnostic CT equipment may result in an increase in the
number of cases accurately diagnosed with AAD [2,4–6];
thus we choose CT as a final examination in suspected
AAD. In addition, our 16 helical CT scans are prepared
for emergency patients 24 h a day, so more typical AAD
patients were diagnosed in 2014 and 2015. The expense
of CT is reasonable, and it is now the routine procedure
to identify atypical and typical AAD in our emergency
department.
Although we consider our findings to be valid, our
study has several potential shortcomings. First, the major

limitation of our study lies in the sample size; we showed
that hospital-based databases, which include only patients
who reach our hospital alive, would miss a substantial
proportion of patients who failed to be delivered to
hospital with AAD [3,9]. Second, some probable
AAD patients with chest pain were considered to have
myocardial ischemia and were subsequently hospitalized
in the cardiac ward. Third, our echocardiography team is
limited by their equipment, skills, and shifts, so this test
was hardly used in this study. Fourth, the results of this
data cannot be generalized to clinical sites that perform
a dedicated accelerated diagnostic protocol as standard
evaluation. It is likely that more atypical symptoms will be
found in the future.
In conclusion, for patients with suspected atypical AAD,
an evaluation of the atypical symptoms incorporated with
a high level of D-dimer is used to decide on the execution
of a prompt CT or CTA to diagnose these atypical patients,
which could improve the efficiency of clinical decision
making for the triage in the emergency department
as compared with a standard evaluation strategy.
Furthermore, the duration of the delay in the emergency
department may be shortened. This method for atypical
patients can be accomplished safely, without putting them
at a greater risk for undetected AAD. Our study could allow
physicians and patients to make informed decisions about
the use of this strategy as an option for evaluation when
symptoms are suggestive of AAD. The essential education
directed towards the recognition of atypical symptoms of
AAD for front-line physicians may be beneficial in clinical
practice.
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